entertainment -WSS

entertainment

author：explore 2025-09-06 03:55:47 - browse：14

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Zyn nicotine pouches become unlikely player in latest culture war

hotspot

entertainment

hotspot

WSS

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Colorectal cancer study finds potential in overlooked immune cell

Humana’s losses in Medicare Advantage tank its stock

Colorectal cancer study finds potential in overlooked immune cell

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Phenylephrine and the overlooked value of the placebo effect

focus

entertainment

focus

Hollywood unions extend contract negotiations for actors

Sana to lay off nearly a third of staff, de

Psychedelics group wrestles with new pharma identity

The future of health care in the House

Affirmative action in medical school literally saved lives

FDA authorizes Novavax’s updated Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare drug price negotiation legal challenge met with skepticism

Anesthesiologist group: stop taking Ozempic before surgery

Bristol 'take

focus

How generative AI ratchets up security threats for health systems

Why Medicare shouldn’t cover every FDA

Was Amgen transparent enough on FDA's concern on cancer drug?

Merck CEO won’t testify in Senate, citing no expertise in drug prices

How generative AI ratchets up security threats for health systems

Wegovy leads to weight loss. Can it treat depression, too?

hotspot

entertainment

hotspot

focus